Stock Events

Stock Events

Search...

CRISPR Therapeutics (CRSP) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-2.13

-1.05

0.02

1.1

Details

Expected EPS

-1.360873

Actual EPS

-1.43

Surprise EPS

-0.07

Surprise Percent

+5.08%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.43 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.